The Transfection Market is growing with factors such as increasing occurrences of chronic diseases and growing demand of chimeric genes. Development of synthetic biology products also acts as a major factor for the growth of the market. Large-scale transfections used in clinical research and utilization of biopharmaceuticals in the production of proteins have also given a boom to the transfection market.
Exploration of emerging market has propelled the demand of the market. However, high costs of transfection products and cell damage induced by transfection methods have decreased the demand of the market.
Global Transfection Market Scenario
According to Data Bridge Market Research, the market for global transfection in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Thermofisher Scientific Inc., which accounts an estimated market share of approximately 18.63% in the market. The company has gained outstanding sale by providing advanced transfection reagents and instruments.
- In May 2017, Thermofisher Scientific Inc. launched endotoxin-free plasmid DNA isolation products, which is used to obtain advanced transfection quality plasmid DNA in less interval of time that is within 90 minutes. This product has fulfilled the need for faster protein expressions without compromising the quantity and quality of the obtained DNA. This product launch boosted the company’s product portfolio.
Trends Impacting the Transfection Market
Now the question is which other regions that Thermofisher Scientific Inc., Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd), QIAGEN are targeting? Data Bridge Market Research has forecasted a large growth in North America transfection market and the market leaders are targeting U.S. and Canada to be their next pocket revenue for 2021.
The transfection market is becoming more competitive with companies such as Thermofisher Scientific Inc., Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd), QIAGEN. These are the top dominating companies in transfection market and are launching more new drugs in the market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global transfection market.
For more analysis on the transfection market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-transfection-market
Transfection Market Developments
- In October 2018, Thermofisher Scientific Inc. collaborated with the Symphogen in order to deliver quality workflow and innovative characterization for the development and discovery of advanced solutions. This collaboration accelerated the company’s research and development activities and allowed it to enhance the manufacturing and sales of advanced reagents and tools.
- In October 2017, Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd) signed a licence agreement with the Ncardia. The company has signed the agreement for modifying the product portfolio of the company by the genetic manipulation techniques which incorporates transfection methodology. As Roche Molecular Systems, Inc. is continuously engaged in manufacturing of highly quality transfection reagent this agreement allowed the company to enhance its product sales.
Scope of the Global Transfection Market
Global transfection market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Belgium, Ireland, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific , Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Egypt and Rest of Middle East & Africa.
- All country based analysis of the global transfection market is further analyzed based on maximum granularity into further segmentation. On the basis of type, the transfection market is segmented into transient transfection, stable transfection. On the basis of methods, the transfection market is segmented into non-viral methods, viral methods. On the basis of CRISPR transfection methods, the transfection market is segmented into non-viral methods, viral methods. On the basis of products, the transfection market is segmented into reagents & kits, instrument, software. On the basis of organism, the transfection market is segmented into mammalian cells, plants, fungi, virus, and bacteria. On the basis of types of molecule, the transfection market is segmented into plasmid DNA , small interfering RNA (siRNA), proteins, DNA oligonucleotides, ribonucleoprotein complexes (RNPs), others. On the basis of application, the transfection market is segmented into In Vitro Application, In Vivo Application, Bioproduction, Others. On the basis of stage, the transfection market is segmented into research, preclinical, clinical phases, and commercial. On the basis of end user, the transfection market is segmented into biopharma, contract research organizations (CROs), contract manufacturing organization/contract development and manufacturing organization (CMOs/CDMOs), academia, hospitals, clinical labs and others. On the basis of distribution channel, the transfection market is segmented into direct tender, retail sales, others.
To know more about the study https://www.databridgemarketresearch.com/reports/global-transfection-market
Key Pointers Covered in Transfection Market Industry Trends and Forecast to 2027
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market value and over view of transfection market
- Company profiling of top eight players of transfection market
Key Market Competitors Covered in the Report
- Mirus Bio LLC.
- Promega Corporation
- Polyplus Transfection
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Lonza
- MaxCyte, Inc.
- Altogen Biosystems
- SBS Genetech
- FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation)
- Avanti Polar Lipids (A Subsidiary of Croda International Plc)
- PerkinElmer chemagen Technologie GmbH (A Subsidiary of PerkinElmer Inc.)
- Cytiva
- Geno Technology Inc., USA
- R&D Systems, Inc.
- Takara Bio Inc.
- Thermofisher Scientific Inc.
- Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd)
- QIAGEN
- OriGene Technologies, Inc.
Above are the key players covered in the report, to know about more and exhaustive list of transfection companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-transfection-market
Research Methodology: Global Transfection Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Manufacturer, Healthcare Industry, Immunologists, Scientists, Research Laboratories
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Related Reports
|
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
|
